Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sanderson

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
The Veterinary Record|March 13, 1993
Experimental transmission of an apparent viral pneumonia in conventional and gnotobiotic pigsP G Halbur, P S Paul, J J Andrews, et al.
Journal of Medicinal Chemistry|July 6, 2021
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)Markus Klein, Michael Busch, Manja Friese-Hamim, et al.
Toxicologic Pathology|April 22, 2009
Strain-related differences in urine composition of male rats of potential relevance to urolithiasisSarah H Tannehill-Gregg, Mark A Dominick, Amy J Reisinger, et al.
Molecular Cancer Therapeutics|May 28, 2021
M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma ModelsMichael P Sanderson, Manja Friese-Hamim, Gina Walter-Bausch, et al.
Toxicologic Pathology|December 21, 2006
Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of actionMark A Dominick, Melvin R White, Thomas P Sanderson, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2006
Activation of T cells by carbamazepine and carbamazepine metabolitesYing Wu, Joseph P Sanderson, John Farrell, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2021
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor responseOlga Bogatyrova, Johanna S M Mattsson, Edith M Ross, et al.
Chemical Research in Toxicology|May 15, 2013
β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosisRosalind E Jenkins, Fiazia S Yaseen, Manal M Monshi, et al.
International Journal of Toxicology|January 7, 2017
In Vitro Metabolite Formation in Human Hepatocytes and Cardiomyocytes and Metabolism and Tissue Distribution in Monkeys of the 2'-C-Methylguanosine Prodrug BMS-986094 : Potential Role in Clinical Cardiovascular ToxicityWenying Li, Kevin J Trouba, Li Ma, et al.
Iscience|December 11, 2020
SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET AlterationsLinda Pudelko, Frank Jaehrling, Christof Reusch, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
The Veterinary Record|March 13, 1993
Experimental transmission of an apparent viral pneumonia in conventional and gnotobiotic pigsP G Halbur, P S Paul, J J Andrews, et al.
Journal of Medicinal Chemistry|July 6, 2021
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)Markus Klein, Michael Busch, Manja Friese-Hamim, et al.
Toxicologic Pathology|April 22, 2009
Strain-related differences in urine composition of male rats of potential relevance to urolithiasisSarah H Tannehill-Gregg, Mark A Dominick, Amy J Reisinger, et al.
Molecular Cancer Therapeutics|May 28, 2021
M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma ModelsMichael P Sanderson, Manja Friese-Hamim, Gina Walter-Bausch, et al.
Toxicologic Pathology|December 21, 2006
Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of actionMark A Dominick, Melvin R White, Thomas P Sanderson, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2006
Activation of T cells by carbamazepine and carbamazepine metabolitesYing Wu, Joseph P Sanderson, John Farrell, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2021
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor responseOlga Bogatyrova, Johanna S M Mattsson, Edith M Ross, et al.
Chemical Research in Toxicology|May 15, 2013
β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosisRosalind E Jenkins, Fiazia S Yaseen, Manal M Monshi, et al.
International Journal of Toxicology|January 7, 2017
In Vitro Metabolite Formation in Human Hepatocytes and Cardiomyocytes and Metabolism and Tissue Distribution in Monkeys of the 2'-C-Methylguanosine Prodrug BMS-986094 : Potential Role in Clinical Cardiovascular ToxicityWenying Li, Kevin J Trouba, Li Ma, et al.
Iscience|December 11, 2020
SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET AlterationsLinda Pudelko, Frank Jaehrling, Christof Reusch, et al.
Pageof 17